Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Cerebral Ischemia clinical trials

3 of 5 indexed Cerebral Ischemia trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Cerebral Ischemia: 5 US clinical trials tracked, 3 recruiting.

Cerebral Ischemia is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Hospital for Special Surgery, New York, running 1 of these trials.

Enrollment posture brief

Registry condition cerebral-ischemia

OPEN 3 | RECR 60% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cerebral Ischemia (this)60%
Open-enrollment share among volume-matched conditions near Cerebral Ischemia

Cerebral Ischemia lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cerebral Ischemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cerebral Ischemia is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cerebral Ischemia research.

    Hospital for Special Surgery, New York accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Cerebral Ischemia trials plan to enrol fewer than 100 people.

    Median target enrolment is 34 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Cerebral Ischemia research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Cerebral Ischemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Non-invasive Cardiac Output Monitor (NICOM) Device
1 trials
Casmed Fore-Sight Elite Device
1 trials
Endovascular autologous mitochondrial transplantation Other
1 trials
Intravenous and Intranasal BMSC Procedure
1 trials
No intervention Other
1 trials

US sites by state

Facility locations filed on Cerebral Ischemia trials. A trial with sites in several states counts in each.

Washington 1 trials
New York 1 trials
Maryland 1 trials
Florida 1 trials
Connecticut 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cerebral Ischemia page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cerebral Ischemia condition card totals 5 registered trials; most-linked intervention Non-invasive Cardiac Output Monitor (NICOM); top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.